Top compounds associated with response to SH2D1B


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC -0.023 0.5
mRNA Sorafenib CCLE pan-cancer AAC -0.032 0.5
mRNA etomoxir CTRPv2 pan-cancer AAC -0.026 0.5
mRNA NSC95397 CTRPv2 pan-cancer AAC -0.022 0.5
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA JW-55 CTRPv2 pan-cancer AAC -0.051 0.5
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.024 0.5
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Irinotecan CCLE pan-cancer AAC -0.035 0.5
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.023 0.5
Download CSV